Explore more publications!

Press Releases

3 E Network Announces the Signing of Land Lease Agreement with City of Mikkeli, Finland
inamo Launches AI-Powered Qualitative Research Suite Tailored for Nordic Innovators
Democratizing Data Architecture: Ellie Technologies Launches Ellie Solo
Why Productivity Growth Has Stalled: New Research Shows Leadership Systems — Not People — Are the Bottleneck
Windrose long-range EV truck Completes ISO 15118-20 based MCS Charging Test at Kempower Headquarters in Finland
Finland Set to Raise Military Reserve Age to 65

Finland Set to Raise Military Reserve Age to 65

Unigraf Introduces Industry-First Computer Vision Technology for HDMI Testing
3 E Network Signed a Master Services Agreement with Orka Technologies to Develop a 26MW AI Data Center in Finland
Canary and VTT Finalize Licensing Agreement for Technology to Enable Development of Canary’s Cardiovascular Program
Takomo Golf Acquires Otso Golf’s Low-Torque Putter Technologies and Design Capabilities
Amarin Announces Preliminary 2025 Financial Highlights and Operational Accomplishments, Including Achieving Positive Cash Flow; Company Well Positioned to Capture Global Growth Opportunities
Virtune AB (Publ) ("Virtune") has completed the rebalancing for December 2025 of its Virtune Stablecoin Index ETP
VIVUS Shares Progress on Pipeline and Key Program Milestones During the 44th Annual J.P. Morgan Healthcare Conference
Xraised Interview with Daahir Abdulle: A Visionary Behind Daahir Abdulle Designs
Orion Pharma announces the initiation of TEADES Phase 2 trial of ODM-212 in Malignant Pleural Mesothelioma (MPM) and Epithelioid Hemangioendothelioma (EHE)
Amarin Applauds Breakthroughs In Therapies For Patients With Elevated Triglycerides; Company’s VASCEPA®/VAZKEPA® (Icosapent Ethyl) Franchise Well Positioned To Benefit Globally From Broadened Category Commercialization
Vaisala Xweather Annual Lightning Report 2025: U.S. lightning hits eight-year high
DayOne Data Centers Announces Over US$2.0 Billion Series C Financing to Accelerate Global Digital Infrastructure Expansion
Virtune AB (Publ) ("Virtune") has completed the monthly rebalancing for December 2025 of its Virtune Crypto Altcoin Index ETP
Herantis Pharma - Phase 1b biomarker data show clear evidence of biological response to HER-096 in people with Parkinson's disease

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions